Contact this trialFirst, we need to learn more about you.
Small Molecule Inhibitor
DF-003 Safety and Tolerability Study in Healthy Subjects
Recruiting0 awardsPhase 1
Cypress, California
This trial evaluates the safety, tolerability, and drug metabolism of DF-003, a new drug being studied for its potential to treat chronic kidney disease. Up to 96 healthy volunteers will be monitored for adverse effects and data on physical/eye exams, ECGs, etc. will be collected.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.